Key Ventricular Assist Devices Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The competitive landscape of the ventricular assist devices market is rapidly evolving as established key players, healthcare giants, and new entrants are investing in including novel medicines. Key players in the market are focused on developing new technologies and products that cater to the stringent regulatory norms and consumer demand. These key players are adopting several strategies, such as mergers and acquisitions, joint ventures, partnerships, and novel product launches, to enhance their product base and strengthen their market position.
Top 15 Global Manufacturers in the Ventricular Assist Devices Market:
|
Company Name |
Country of Origin |
Est. Market Share (2024) |
|
Abbott Laboratories |
USA |
17.4% |
|
Medtronic plc |
Ireland (Global HQ USA) |
13.4% |
|
Berlin Heart GmbH |
Germany |
9.5% |
|
Abiomed Inc. (Johnson & Johnson MedTech) |
USA |
9.2% |
|
Jarvik Heart Inc. |
USA |
8.2% |
|
Terumo Corporation |
Japan |
xx% |
|
SynCardia Systems LLC |
USA |
xx% |
|
Evaheart Inc. |
Japan |
xx% |
|
Calon Cardio-Technology Ltd |
UK |
xx% |
|
CH Biomedical Inc. |
China |
xx% |
|
Leviticus Cardio Ltd. |
Israel |
xx% |
|
CoreMedic GmbH |
Germany |
xx% |
|
ReliantHeart Inc. |
USA |
xx% |
|
Sun Medical Technology Research Corp. |
Japan |
xx% |
|
Insightra Medical Inc. |
USA |
xx% |
Below are the areas covered for each company in the global ventricular assist devices market:
